SL Science Holding SLBT
NASDAQ SLBT
$1.27 +0.06 (+5.00%)
As of: Oct 29, 2026 · 11:12 AM EDT

SL Science Holding (SLBT) Operating Leases (2025)

Updated

SL Science Holding's Operating Leases was $64,742 in Q4 2025.

Analysis

SL Science Holding (SLBT) Operating Leases (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,226.20 Bn 1,194.79 Bn 19.71 Bn
2 Johnson & Johnson 662.74 Bn 582.60 Bn 17.30 Bn
3 AbbVie 513.20 Bn 486.32 Bn 12.70 Bn
4 Merck 365.92 Bn 320.30 Bn 12.21 Bn
5 Novartis Ag 311.30 Bn 284.53 Bn -
6 Astrazeneca 270.37 Bn 244.05 Bn 12.86 Bn
7 Amgen 248.93 Bn 204.33 Bn 7.24 Bn
8 Gilead Sciences 200.67 Bn 174.87 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.44 Bn 10.94 Bn
10 SL Science Holding 2.77 Bn 2.76 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 64,742.00
API Access

SL Science Holding Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=SLBT&period=max&api_key=YOUR_API_KEY